Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | PALB2 |
| Variant | H46Y |
| Impact List | missense |
| Protein Effect | unknown |
| Gene Variant Descriptions | PALB2 H46Y lies within the DNA-binding, and BRCA1 and RAD51-interacting regions of the Palb2 protein (UniProt.org). H46Y results in subcellular localization, RAD51 foci formation, and homologous repair activity similar to wild-type Palb2 in cultured cells and BRCA1 binding similar to wild-type protein in a mammalian two-hybrid assay, but fails to rescue PARP inhibitor sensitivity in PALB2-null cells in culture (PMID: 31586400), and therefore, its effect on Palb2 protein function is unknown. |
| Associated Drug Resistance | |
| Category Variants Paths |
PALB2 mutant PALB2 H46Y |
| Transcript | NM_024675.4 |
| gDNA | chr16:g.23637925G>A |
| cDNA | c.136C>T |
| Protein | p.H46Y |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| XM_017023672.2 | chr16:g.23637925G>A | c.136C>T | p.H46Y | RefSeq | GRCh38/hg38 |
| NM_001407300.1 | chr16:g.23637925G>A | c.136C>T | p.H46Y | RefSeq | GRCh38/hg38 |
| NM_024675.3 | chr16:g.23637925G>A | c.136C>T | p.H46Y | RefSeq | GRCh38/hg38 |
| NM_001407302.1 | chr16:g.23637925G>A | c.136C>T | p.H46Y | RefSeq | GRCh38/hg38 |
| NM_001407297.1 | chr16:g.23637925G>A | c.136C>T | p.H46Y | RefSeq | GRCh38/hg38 |
| NM_001407298.1 | chr16:g.23637925G>A | c.136C>T | p.H46Y | RefSeq | GRCh38/hg38 |
| XM_017023673.2 | chr16:g.23637925G>A | c.136C>T | p.H46Y | RefSeq | GRCh38/hg38 |
| NM_024675.4 | chr16:g.23637925G>A | c.136C>T | p.H46Y | RefSeq | GRCh38/hg38 |
| NM_001407299.1 | chr16:g.23637925G>A | c.136C>T | p.H46Y | RefSeq | GRCh38/hg38 |
| NM_001407301.1 | chr16:g.23637925G>A | c.136C>T | p.H46Y | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| PALB2 H46Y | osteosarcoma | sensitive | Olaparib | Preclinical - Cell culture | Actionable | In a preclinical study, osteosarcoma cells expressing PALB2 H46Y were sensitive to treatment with Lynparza (olaparib), demonstrating decreased cell growth in culture (PMID: 31586400). | 31586400 |
| PALB2 H46Y | Advanced Solid Tumor | sensitive | Olaparib | Preclinical - Cell culture | Actionable | In a preclinical study, cells expressing PALB2 H46Y were sensitive to treatment with Lynparza (olaparib), demonstrating decreased cell growth in culture (PMID: 31586400). | 31586400 |